Tag: Bristol-Myers Squibb Co

AstraZeneca may buck a decade of pharma strategy to buy U.S. scale

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration

Dow is surging, Nasdaq is lagging. The two factors splitting the markets in half: Live updates

‘Mag 7’ earnings, Fed meeting will test a stock market near all-time highs. Here’s what’s ahead

Here’s our monthly update on all 31 portfolio stocks, including 3 on the buy list

Trump tariff fallout: Some industries grapple with lingering effects one year later

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

Here’s an update on our 4th Industrial Revolution stocks and the rest of the portfolio